Half Title Page.
Preface to the Fifth Edition.
Preface to the First Edition.
1: Breast Anatomy and Development.
2: Breast Anatomy and Development.
3: Stem Cells in Breast Development and Carcinogenesis: Concepts and Clinical Perspectives.
4: Diagnosis and Management of Benign Breast Disease.
5: Physical Examination of the Breast.
6: Management of the Palpable Breast Mass.
7: Management of Disorders of the Ductal System and Infections.
8: Management of Breast Pain.
9: Abnormalities of the Breast in Pregnancy and Lactation.
10: Management of Gynecomastia.
11: Pathology of Benign Breast Disorders.
12: Breast Imaging and Image-Guided Biopsy Techniques.
13: Breast Cancer Screening.
14: Imaging Analysis: Mammography.
15: Imaging Analysis: Ultrasonography.
16: Imaging Analysis: Magnetic Resonance Imaging.
17: New Breast Imaging Techniques.
18: Image-Guided Biopsy of Nonpalpable Breast Lesions.
19: Epidemiology and Assessing and Managing Risk.
20: Inherited Genetic Factors and Breast Cancer.
21: Genetic Testing and Management of Patients with Hereditary Breast Cancer.
22: Nongenetic Factors in the Causation of Breast Cancer.
23: Management of Other High Risk Patients.
25: In Situ Carcinoma.
26: Ductal Carcinoma In Situ and Other Intraductal Lesions: Pathology, Immunohistochemistry, and Molecular Alterations.
27: Lobular Carcinoma In Situ: Biology and Management.
28: Ductal Carcinoma In Situ and Microinvasive Carcinoma.
29: Pathology and Biological Markers of Invasive Breast Cancer.
30: Genomic Events in Breast Cancer Progression.
31: Pathology of Invasive Breast Cancer.
32: Estrogen and Progesterone Receptor Testing for Prognosis and Prediction.
33: HER2/ERBB2 Testing: Assessment of Status for Targeted Therapies.
34: Clinical and Pathologic Prognostic and Predictive Factors.
35: Genomics, Prognosis, and Therapeutic Interventions.
36: Bone Marrow Micrometastases and Circulating Tumor Cells.
37: Management of Primary Invasive Breast Cancer.
38: Evaluation of Patients for Metastasis Prior to Primary Therapy.
39: Staging of Breast Cancer.
41: Contralateral Prophylactic Mastectomy.
42: Breast-Conserving Therapy.
43: Breast Reconstruction.
44: Sentinel Lymph Node Biopsy.
45: Axillary Dissection.
46: Preserving and Restoring Function after Local Treatment.
48: Local Management of the Axilla.
49: Postmastectomy Radiation Therapy.
50: Adjuvant Systemic Therapy: Endocrine Therapy.
51: Adjuvant Systemic Chemotherapy in Early Breast Cancer.
52: Adjuvant Chemo Endocrine Therapy.
53: Adjuvant and Preoperative Systemic Therapy for HER2-Positive Breast Cancer.
54: Adjuvant Systemic Therapy: Bone-Targeted Treatments.
55: Pharmacogenomics of Systemic Therapy.
56: Implications of Obesity in Breast Cancer.
57: Lifestyle Issues in Breast Cancer Survivors.
58: Management of Menopausal Symptoms in Breast Cancer Survivors.
59: Long-Term and Late Effects of Primary Curative Intent Therapy: Neurocognitive, Cardiac, and Secondary Malignancies.
60: Adjuvant Systemic Therapy Treatment Guidelines.
61: Preoperative Systemic Therapy.
62: Preoperative Chemotherapy for Operable Breast Cancer.
63: Preoperative Endocrine Therapy for Operable Breast Cancer.
64: Pathologic Assessment of Treatment Response after Neoadjuvant Therapy.
65: Local-Regional Therapy following Systemic Treatment.
66: Locally Advanced Breast Cancer.
67: Inflammatory Breast Cancer.
68: Preoperative Systemic Therapy for Breast Cancer.
69: Special Therapeutic Problems.
70: Male Breast Cancer.
71: Phyllodes Tumors.
72: Paget's Disease.
73: Nonepithelial Malignancies of the Breast.
74: Breast Cancer during Pregnancy and Subsequent Pregnancy in Breast Cancer Survivors.
75: Occult Primary Cancer with Axillary Metastases.
76: Evaluation after Primary Therapy and Management of Recurrent Bre